SeqLL Installs true Single Molecule Sequencing (tSMS®) Instrument to support oncology research by Dr. David Ting, MD at the Harvard-MGH Cancer CenterNovember 19, 2025Wednesday, November 3, 2025 WOBURN, MA ‐‐ SeqLL, LLC announced today that it has installed a true Single Molecule Sequencing (tSMS) Instrument at the Harvard‐MGH Cancer Center to support [...]
